Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer

Cell Reports

Volumn 11, Issue 10, 2015, Pages 1549-1563

  Su, Ying ^a,b,c,j   Subedee, Ashim ^a,c   Bloushtain Qimron, Noga ^a,k   Savova, Virginia ^a,c   Krzystanek, Marcin ^d   Li, Lewyn ^a   Marusyk, Andriy ^a,b,c   Tabassum, Doris P ^a,c   Zak, Alexander ^a,l   Flacker, Mary Jo ^e   Li, Mei ^a,m   Lin, Jessica J ^a,b,c   Sukumar, Saraswati ^e   Suzuki, Hiromu ^f   Long, Henry ^a   Szallasi, Zoltan ^d,g   Gimelbrant, Alexander ^a,c   Maruyama, Reo ^a,b,c,f   Polyak, Kornelia ^a,b,c,h,i  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h HARVARD STEM CELL INSTITUTE   (United States)

ⁱ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^j Infinity Pharmaceuticals Inc   (United States)

^k EMEA Site Intelligence and Activation   (Israel)

^l Pfizer Research   (United States)

^m Pfizer Research Business Technologies ^*  (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL LIKE BREAST CANCER; CELL FUSION; CELL HETEROGENEITY; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA CONTENT; DNA METHYLATION; EPIGENETICS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENE FREQUENCY; HUMAN; HUMAN CELL; MORPHOLOGY; NERVE CELL PLASTICITY; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; TRANSCRIPTION REGULATION; BREAST TUMOR; FEMALE; GENE EXPRESSION; GENETICS; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PROCEDURES; PROMOTER REGION; TUMOR CELL LINE;

FOXA1 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR;

BREAST NEOPLASMS; CELL FUSION; CELL LINE, TUMOR; EPIGENOMICS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MCF-7 CELLS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84937643828     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.05.011     Document Type: Article

References (41)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
2. Beltran A.S., Graves L.M., Blancafort P. Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function. Oncogene 2014, 33:4767-4777.
3. Choudhury S., Almendro V., Merino V.F., Wu Z., Maruyama R., Su Y., Martins F.C., Fackler M.J., Bessarabova M., Kowalczyk A., et al. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell 2013, 13:117-130.
4. Collas P., Gammelsaeter R. Novel approaches to epigenetic reprogramming of somatic cells. Cloning Stem Cells 2007, 9:26-32.
5. Collas P., Taranger C.K. Epigenetic reprogramming of nuclei using cell extracts. Stem Cell Rev. 2006, 2:309-317.
6. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352. METABRIC Group.
7. Davidson R.L., Gerald P.S. Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet. 1976, 2:165-176.
8. Egli D., Birkhoff G., Eggan K. Mediators of reprogramming: transcription factors and transitions through mitosis. Nat. Rev. Mol. Cell Biol. 2008, 9:505-516.
9. Fackler M.J., Umbricht C.B., Williams D., Argani P., Cruz L.A., Merino V.F., Teo W.W., Zhang Z., Huang P., Visvananthan K., et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011, 71:6195-6207.
10. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861. International HapMap Consortium.
11. Ganesan S., Silver D.P., Greenberg R.A., Avni D., Drapkin R., Miron A., Mok S.C., Randrianarison V., Brodie S., Salstrom J., et al. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 2002, 111:393-405.
12. Hajra K.M., Ji X., Fearon E.R. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 1999, 18:7274-7279.
13. Hanna J.H., Saha K., Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010, 143:508-525.
14. Hnisz D., Abraham B.J., Lee T.I., Lau A., Saint-André V., Sigova A.A., Hoke H.A., Young R.A. Super-enhancers in the control of cell identity and disease. Cell 2013, 155:934-947.
15. Kruidenier L., Chung C.W., Cheng Z., Liddle J., Che K., Joberty G., Bantscheff M., Bountra C., Bridges A., Diallo H., et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012, 488:404-408.
16. Lehmann B.D., Bauer J.A., Chen X., Sanders M.E., Chakravarthy A.B., Shyr Y., Pietenpol J.A. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 2011, 121:2750-2767.
17. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913. kConFab.
18. Liu S., Ginestier C., Charafe-Jauffret E., Foco H., Kleer C.G., Merajver S.D., Dontu G., Wicha M.S. BRCA1 regulates human mammary stem/progenitor cell fate. Proc. Natl. Acad. Sci. USA 2008, 105:1680-1685.
19. MacDougall J.R., Matrisian L.M. Targets of extinction: identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes. J. Cell Sci. 2000, 113:409-423.
20. Mansour A.A., Gafni O., Weinberger L., Zviran A., Ayyash M., Rais Y., Krupalnik V., Zerbib M., Amann-Zalcenstein D., Maza I., et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
21. - stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 2011, 121:2723-2735.
22. Maruyama R., Choudhury S., Kowalczyk A., Bessarabova M., Beresford-Smith B., Conway T., Kaspi A., Wu Z., Nikolskaya T., Merino V.F., et al. Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium. PLoS Genet. 2011, 7:e1001369.
23. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
24. Molyneux G., Geyer F.C., Magnay F.A., McCarthy A., Kendrick H., Natrajan R., Mackay A., Grigoriadis A., Tutt A., Ashworth A., et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010, 7:403-417.
25. Park S.Y., Gönen M., Kim H.J., Michor F., Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J. Clin. Invest. 2010, 120:636-644.
26. Park S.Y., Lee H.E., Li H., Shipitsin M., Gelman R., Polyak K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin. Cancer Res. 2010, 16:876-887.
27. Peinado H., Alečković M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., Hergueta-Redondo M., Williams C., García-Santos G., Ghajar C., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 2012, 18:883-891.
28. Polakis P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 2007, 17:45-51.
29. Polyak K. Breast cancer: origins and evolution. J. Clin. Invest. 2007, 117:3155-3163.
30. Polyak K., Waldman T., He T.C., Kinzler K.W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996, 10:1945-1952.
31. Prat A., Perou C.M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 2011, 5:5-23.
32. Richardson A.L., Wang Z.C., De Nicolo A., Lu X., Brown M., Miron A., Liao X., Iglehart J.D., Livingston D.M., Ganesan S. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9:121-132.
33. Shah S.P., Roth A., Goya R., Oloumi A., Ha G., Zhao Y., Turashvili G., Ding J., Tse K., Haffari G., et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399.
34. Shipitsin M., Campbell L.L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M., et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007, 11:259-273.
35. Sjöblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
36. Takeichi M., Nimura K., Mori M., Nakagami H., Kaneda Y. The transcription factors Tbx18 and Wt1 control the epicardial epithelial-mesenchymal transition through bi-directional regulation of Slug in murine primary epicardial cells. PLoS ONE 2013, 8:e57829.
37. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
38. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J.J., Lötvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
39. Vaz-Luis I., Ottesen R.A., Hughes M.E., Mamet R., Burstein H.J., Edge S.B., Gonzalez-Angulo A.M., Moy B., Rugo H.S., Theriault R.L., et al. Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study. J. Clin. Oncol. 2014, 32:2142-2150.
40. Visvader J.E. Cells of origin in cancer. Nature 2011, 469:314-322.
41. Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.